Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Quigley

Showing results (701-710 of 748) with videos related to

Pageof 75
Sort By:
Cancer Immunology Research|March 2, 2016
Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1Jarushka Naidoo, Katja Schindler, Christiane Querfeld, et al.
NPJ Genomic Medicine|September 22, 2021
Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT SignaturesNicholas R Rydzewski, Erik Peterson, Joshua M Lang, et al.
NPJ Breast Cancer|September 11, 2021
Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3<sup>VNTR</sup> polymorphisms and gene co-expressionJaume Fores-Martos, Raimundo Cervera-Vidal, Julia Sierra-Roca, et al.
European Journal of Endocrinology|July 15, 2017
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome MeetingClaus H Gravholt, Niels H Andersen, Gerard S Conway, et al.
Acta Ophthalmologica|August 15, 2018
Protruded retinal layers within the optic nerve head neuroretinal rimLucas A Torres, Jayme R Vianna, Faisal Jarrar, et al.
JAMA Oncology|September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate CancerRahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
Nature|July 21, 2022
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancerCameron Herberts, Matti Annala, Joonatan Sipola, et al.
The Journal of Clinical Investigation|October 1, 2024
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancerXiaolin Zhu, Tatyanah Farsh, Daniël Vis, et al.
Urologic Oncology|July 7, 2020
Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancerDaniel H Kwon, Li Zhang, David A Quigley, et al.
Cell Reports|March 8, 2016
Large-Scale Profiling of Kinase Dependencies in Cancer Cell LinesJames Campbell, Colm J Ryan, Rachel Brough, et al.
Pageof 75

Showing results (701-710 of 748) with videos related to

Sort By:
Pageof 75
Cancer Immunology Research|March 2, 2016
Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1Jarushka Naidoo, Katja Schindler, Christiane Querfeld, et al.
NPJ Genomic Medicine|September 22, 2021
Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT SignaturesNicholas R Rydzewski, Erik Peterson, Joshua M Lang, et al.
NPJ Breast Cancer|September 11, 2021
Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3<sup>VNTR</sup> polymorphisms and gene co-expressionJaume Fores-Martos, Raimundo Cervera-Vidal, Julia Sierra-Roca, et al.
European Journal of Endocrinology|July 15, 2017
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome MeetingClaus H Gravholt, Niels H Andersen, Gerard S Conway, et al.
Acta Ophthalmologica|August 15, 2018
Protruded retinal layers within the optic nerve head neuroretinal rimLucas A Torres, Jayme R Vianna, Faisal Jarrar, et al.
JAMA Oncology|September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate CancerRahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.
Nature|July 21, 2022
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancerCameron Herberts, Matti Annala, Joonatan Sipola, et al.
The Journal of Clinical Investigation|October 1, 2024
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancerXiaolin Zhu, Tatyanah Farsh, Daniël Vis, et al.
Urologic Oncology|July 7, 2020
Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancerDaniel H Kwon, Li Zhang, David A Quigley, et al.
Cell Reports|March 8, 2016
Large-Scale Profiling of Kinase Dependencies in Cancer Cell LinesJames Campbell, Colm J Ryan, Rachel Brough, et al.
Pageof 75